002162.SZ
悦心健康
SZSE · Industrials · C 制造业 · CN
CNY 3.92
−2.00%Year over year
Reported trailing growth
- Revenue
- -8.7%
- EBITDA
- —
- EBIT
- +112.9%
- EPS
- +108.1%
- Free cash flow
- -40.8%
- Operating cash flow
- -14.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -3.0%
- EBITDA
- -30.6%
- EBIT
- -56.9%
- Net income
- -63.3%
- EPS
- -63.2%
- Free cash flow
- -34.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026